Infectious disease experts say the mRNA technology used in vaccines is safe, and they credit its development during the first ...

With a market cap of $10.7 billion, Moderna, Inc. (MRNA) is a biotechnology company specializing in the development of ...

The US Department of Health and Human Services is to cancel contracts and pull funding for some vaccines that are being developed to fight respiratory viruses like Covid-19 and the flu. Robert F ...

The Department of Health and Human Services is going to cancel contracts and pull funding for these projects, Robert F ...

Respiratory syncytial virus is the second most common cause of infant mortality and a major cause of morbidity and mortality in older adults (aged >60 years). Efforts to develop a respiratory ...